A phase 3 trial of cytisine for the treatment of smoking cessation.
Phase of Trial: Phase III
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Cytisine (Primary)
- Indications Smoking withdrawal
- Focus Registrational; Therapeutic Use
- Sponsors Achieve Life Sciences
- 16 Aug 2017 New trial record
- 10 Aug 2017 According to an Achieve Life Sciences media release, company expects to commence this Phase 3 trial of cytisine in the United States in the first-half of 2018.